Logo image of CG

CARLYLE GROUP INC/THE (CG) Stock Fundamental Analysis

NASDAQ:CG - Nasdaq - US14316J1088 - Common Stock - Currency: USD

58.31  -0.66 (-1.12%)

Fundamental Rating

4

Taking everything into account, CG scores 4 out of 10 in our fundamental rating. CG was compared to 233 industry peers in the Capital Markets industry. CG has a medium profitability rating, but doesn't score so well on its financial health evaluation. CG is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CG had positive earnings in the past year.
CG had a negative operating cash flow in the past year.
Of the past 5 years CG 4 years were profitable.
In multiple years CG reported negative operating cash flow during the last 5 years.
CG Yearly Net Income VS EBIT VS OCF VS FCFCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B 4B

1.2 Ratios

CG's Return On Assets of 4.50% is fine compared to the rest of the industry. CG outperforms 66.52% of its industry peers.
CG has a Return On Equity of 19.45%. This is amongst the best in the industry. CG outperforms 87.12% of its industry peers.
CG has a Return On Invested Capital of 6.16%. This is in the better half of the industry: CG outperforms 72.96% of its industry peers.
Industry RankSector Rank
ROA 4.5%
ROE 19.45%
ROIC 6.16%
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
CG Yearly ROA, ROE, ROICCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

CG's Profit Margin of 19.00% is in line compared to the rest of the industry. CG outperforms 57.94% of its industry peers.
CG's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 24.15%, CG is in line with its industry, outperforming 45.92% of the companies in the same industry.
CG's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 60.12%, CG is in the better half of the industry, outperforming 67.38% of the companies in the same industry.
CG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 24.15%
PM (TTM) 19%
GM 60.12%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
CG Yearly Profit, Operating, Gross MarginsCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for CG has been reduced compared to 1 year ago.
CG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CG has been reduced compared to a year ago.
CG Yearly Shares OutstandingCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CG Yearly Total Debt VS Total AssetsCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CG has an Altman-Z score of 1.04. This is a bad value and indicates that CG is not financially healthy and even has some risk of bankruptcy.
CG has a Altman-Z score (1.04) which is in line with its industry peers.
A Debt/Equity ratio of 1.73 is on the high side and indicates that CG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.73, CG is doing worse than 76.39% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.73
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACCN/A
WACCN/A
CG Yearly LT Debt VS Equity VS FCFCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

CG has a Current Ratio of 0.42. This is a bad value and indicates that CG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.42, CG is not doing good in the industry: 79.83% of the companies in the same industry are doing better.
A Quick Ratio of 0.42 indicates that CG may have some problems paying its short term obligations.
CG has a Quick ratio of 0.42. This is in the lower half of the industry: CG underperforms 79.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
CG Yearly Current Assets VS Current LiabilitesCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.70% over the past year.
The Earnings Per Share has been growing by 16.58% on average over the past years. This is quite good.
CG shows a strong growth in Revenue. In the last year, the Revenue has grown by 115.65%.
The Revenue has been growing by 9.95% on average over the past years. This is quite good.
EPS 1Y (TTM)4.7%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%12.87%
Revenue 1Y (TTM)115.65%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%1.97%

3.2 Future

The Earnings Per Share is expected to grow by 11.30% on average over the next years. This is quite good.
The Revenue is expected to grow by 12.80% on average over the next years. This is quite good.
EPS Next Y14.22%
EPS Next 2Y15.03%
EPS Next 3Y13.47%
EPS Next 5Y11.3%
Revenue Next Year9.86%
Revenue Next 2Y15.01%
Revenue Next 3Y12.8%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CG Yearly Revenue VS EstimatesCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CG Yearly EPS VS EstimatesCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.39 indicates a correct valuation of CG.
Compared to the rest of the industry, the Price/Earnings ratio of CG is on the same level as its industry peers.
CG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.04, which indicates a correct valuation of CG.
CG's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CG is cheaper than 61.80% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.58, CG is valued rather cheaply.
Industry RankSector Rank
PE 15.39
Fwd PE 12.04
CG Price Earnings VS Forward Price EarningsCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CG is valued a bit cheaper than the industry average as 75.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.85
CG Per share dataCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CG's earnings are expected to grow with 13.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.08
PEG (5Y)0.93
EPS Next 2Y15.03%
EPS Next 3Y13.47%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.39%, CG has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 7.77, CG has a dividend in line with its industry peers.
CG's Dividend Yield is comparable with the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 2.39%

5.2 History

The dividend of CG decreases each year by -1.73%.
CG has been paying a dividend for at least 10 years, so it has a reliable track record.
CG has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-1.73%
Div Incr Years3
Div Non Decr Years4
CG Yearly Dividends per shareCG Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

46.34% of the earnings are spent on dividend by CG. This is a bit on the high side, but may be sustainable.
DP46.34%
EPS Next 2Y15.03%
EPS Next 3Y13.47%
CG Yearly Income VS Free CF VS DividendCG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B
CG Dividend Payout.CG Dividend Payout, showing the Payout Ratio.CG Dividend Payout.PayoutRetained Earnings

More info and screens

CARLYLE GROUP INC/THE

NASDAQ:CG (7/15/2025, 3:32:09 PM)

58.31

-0.66 (-1.12%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners64.4%
Inst Owner Change0%
Ins Owners26.31%
Ins Owner Change-0.13%
Market Cap21.06B
Analysts73.08
Price Target52.78 (-9.48%)
Short Float %5.53%
Short Ratio5.83
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Yearly Dividend1.4
Dividend Growth(5Y)-1.73%
DP46.34%
Div Incr Years3
Div Non Decr Years4
Ex-Date05-19 2025-05-19 (0.35)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.02%
Min EPS beat(2)-6.9%
Max EPS beat(2)16.95%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-8.37%
Max EPS beat(4)16.95%
EPS beat(8)6
Avg EPS beat(8)7.39%
EPS beat(12)9
Avg EPS beat(12)7.09%
EPS beat(16)12
Avg EPS beat(16)12.96%
Revenue beat(2)1
Avg Revenue beat(2)-3.47%
Min Revenue beat(2)-9.92%
Max Revenue beat(2)2.98%
Revenue beat(4)1
Avg Revenue beat(4)-4.68%
Min Revenue beat(4)-9.92%
Max Revenue beat(4)2.98%
Revenue beat(8)3
Avg Revenue beat(8)-0.53%
Revenue beat(12)3
Avg Revenue beat(12)-4.64%
Revenue beat(16)7
Avg Revenue beat(16)25.38%
PT rev (1m)0.31%
PT rev (3m)-8.22%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)-6.54%
EPS NY rev (1m)0.5%
EPS NY rev (3m)-3.26%
Revenue NQ rev (1m)0.52%
Revenue NQ rev (3m)-10.34%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)-6.94%
Valuation
Industry RankSector Rank
PE 15.39
Fwd PE 12.04
P/S 3.69
P/FCF N/A
P/OCF N/A
P/B 3.78
P/tB 4.23
EV/EBITDA 18.85
EPS(TTM)3.79
EY6.5%
EPS(NY)4.84
Fwd EY8.31%
FCF(TTM)-3.5
FCFYN/A
OCF(TTM)-3.27
OCFYN/A
SpS15.81
BVpS15.44
TBVpS13.77
PEG (NY)1.08
PEG (5Y)0.93
Profitability
Industry RankSector Rank
ROA 4.5%
ROE 19.45%
ROCE 7.87%
ROIC 6.16%
ROICexc 6.85%
ROICexgc 13.21%
OM 24.15%
PM (TTM) 19%
GM 60.12%
FCFM N/A
ROA(3y)2.42%
ROA(5y)4.7%
ROE(3y)8.72%
ROE(5y)19.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-39.75%
ROICexcg growth 5Y-2.37%
ROICexc growth 3Y-33.35%
ROICexc growth 5Y-6.78%
OM growth 3Y-18.19%
OM growth 5Y-7.53%
PM growth 3Y-17.81%
PM growth 5Y12.96%
GM growth 3Y-0.37%
GM growth 5Y-5.06%
F-Score6
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 1.73
Debt/FCF N/A
Debt/EBITDA 6.17
Cap/Depr 43.19%
Cap/Sales 1.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z 1.04
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)175.39%
Cap/Depr(5y)144.65%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.7%
EPS 3Y-9.94%
EPS 5Y16.58%
EPS Q2Q%12.87%
EPS Next Y14.22%
EPS Next 2Y15.03%
EPS Next 3Y13.47%
EPS Next 5Y11.3%
Revenue 1Y (TTM)115.65%
Revenue growth 3Y-14.83%
Revenue growth 5Y9.95%
Sales Q2Q%1.97%
Revenue Next Year9.86%
Revenue Next 2Y15.01%
Revenue Next 3Y12.8%
Revenue Next 5YN/A
EBIT growth 1Y276.87%
EBIT growth 3Y-30.32%
EBIT growth 5Y1.66%
EBIT Next Year8.6%
EBIT Next 3Y15.29%
EBIT Next 5Y6.84%
FCF growth 1Y-682.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-884.76%
OCF growth 3YN/A
OCF growth 5YN/A